Can steroids tame deadly pneumonia? new trial aims to find out
NCT ID NCT07152587
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests different doses of steroids for people in the ICU with severe pneumonia caused by adenovirus or Pneumocystis jirovecii. The goal is to see if steroids can reduce the high death rate (25-50%) by calming the body's overactive immune response. About 1,500 adults will be randomly assigned to one of two steroid doses or standard care, and the main outcome is survival at 28 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMMUNITY-ACQUIRED PNEUMONIA (SCAP) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.